Grundy, SM, Cleeman, JI, Daniels, SR, Donato, KA, Eckel, RH, Franklin, BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation
2005; 112: 2735–52.
Bushe, C, Taylor, M, Haukka, J.
Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol
2010; 24 (suppl 4): 17–25.
De Hert, M, Vancampfort, D, Correll, CU, Mercken, V, Peuskens, K, Sweers, K, et al. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry
2011; 199: 99–105.
Mitchell, AJ, Delaffon, V, Lord, O.
Let's get physical: improving the medical care of people with severe mental illness. Adv Psychiatr Treat
2012; 18: 216–25.
Mitchell, AJ, Delaffon, V, Vancampfort, D, Correll, CU, De Hert, M.
Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med
2012; 42: 125–47.
Larsen, JT, Fagerquist, M, Holdrup, M, Christensen, B, Sigalin, C, Nilsson, P.
Metabolic syndrome and psychiatrists' choice of follow-up interventions in patients treated with atypical antipsychotics in Denmark and Sweden. Nord J Psychiatry
2011; 65: 140–6.
Nasrallah, HA, Meyer, JM, Goff, DC, McEvoy, JP, Devis, SM, Stroup, TS, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res
2006; 86: 15–22.
Wilson, E, Randall, C, Patterson, S, Emmerson, B, Moudgil, V, Weaver, T.
Monitoring and management of metabolic abnormalities: mixed-method evaluation of a successful intervention. Australas Psychiatry
2014; 22: 248–53.
Tully, J, Sim, C, Hemani, R, Munir, M, Khalis, N, Fahy, S.
Audit of monitoring of the parameters of metabolic syndrome in patients on clozapine. Psychiatrist
2012; 36: 466–9.
Grol, R, Grimshaw, J.
From best evidence to best practice: effective implementation of change in patients' care. Lancet
2003; 362: 1225–9.
Girlanda, F, Fiedler, I, Ay, E, Barbul, C, Koesters, M.
Guideline implementation strategies for specialist mental healthcare. Curr Opin Psychiatry
2013; 26: 369–75.
Creswell, J, Clark, V.
Design and Conducting Mixed Methods Research. Sage, 2009.
Curtis, J, Newall, HD, Samaras, K.
The heart of the matter: cardiometabolic care in youth with psychosis. Early Interv Psychiatry
2012; 6: 347–53.
Lester, H, Shiers, DE, Rafi, I, Cooper, SJ, Holt, RIG. Positive Cardiometabolic Health Resource: An Intervention Framework for Patients with Psychosis on Antipsychotic Medication. Royal College of Psychiatrists' Centre for Quality Improvement, 2012.
Ritchie, J, Spencer, L.
Qualitative data analysis for applied policy research. In Analysing Qualitative Data (eds Bryman, A, Burgess, R): 173–94. Routledge, 1994.
Owen, RR, Drummond, KL, Viverito, KM, Marchant, K, Pope, SK, Smith, JL, et al. Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation. Implement Sci
2013; 8: 120.
Buckley, PF, Miller, DD, Singer, B, Arena, J, Stirewalt, EM. Clinicians' recognition of the metabolic adverse side effects of antipsychotic medications. Schizophr Res
2005; 79: 281–8.
Goldman, , Larry, S.
Medical illness in patients with schizophrenia. J Clinical Psychiatry
1999; 60 (suppl 21): 10–5.
Parameswaran, SG, Chang, C, Swenson, AK, Shumway, M, Olfson, M, Mangurian, CV. Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists. Schizophr Res
2012; 143: 395–6.
Khan, AY, Shaikh, MR, Ablah, E.
To examine the extent to compliance to the proposed monitoring protocol among practicing psychiatrists for second generation antipsychotics. J Pakistan Med Assoc
2010; 60: 6.
Vanderlip, E, Fiedorowicz, JG, Haynes, W.
Screening, diagnosis and treatment of dyslipidemia among persons with persistent mental illness: a literature review. Psychiatr Serv
2012; 63: 693–701.
Phillips, LS, Branch, WT, Cook, CB, Doyle, JP, Imad, M, El-Kebbi, I, et al. Clinical inertia. Ann Intern Med
2001; 135: 825–34.
Shiers, D, Bradshaw, T, Campion, J.
Health inequalities and psychosis: time for action. Br J Psychiatry
2015; 207: 471–3.